Search Results

Your search for William T. Curry, Jr, MD,William T. Curry, Jr, MD matches 2 pages

Showing 1 - 2

By William T. Curry, MD / December 15, 2013

Valganciclovir in Glioblastoma, Selection Bias, and Flawed Conclusions

As reviewed in this issue of The ASCO Post, Söderberg-Nauclér et al from the Karolinska Institute have written a provocative letter to The New England Journal of Medicine suggesting that long-term administration of valganciclovir (Valcyte), a drug that targets cytomegalovirus (CMV), improves...

cns cancers

By William T. Curry, Jr, MD / May 15, 2014

Surgical Resection of Newly Diagnosed Glioblastoma: What Is the Standard of Care?

The neurosurgeon is often the gateway provider when patients present with what on magnetic resonance imaging (MRI) appears to be a new glioblastoma. Because histology-based diagnosis is a prerequisite for initiating standard therapy with radiation and chemotherapy, the first question that the...

Nov

Today In Oncology

Search Results

Your search for William T. Curry, Jr, MD,William T. Curry, Jr, MD matches 2 pages

Valganciclovir in Glioblastoma, Selection Bias, and Flawed Conclusions

Surgical Resection of Newly Diagnosed Glioblastoma: What Is the Standard of Care?

What Is the Impact of a Colon or Colorectal Cancer Diagnosis on Younger Adults?

International Cancer Organizations Present Collaborative Work During Oncology Event in China

Is There a Role for Neoadjuvant Chemotherapy in HR-Positive, HER2-Negative Early Breast Cancer?

Suicide-Related Mortality in Male AYA Cancer Survivors

Four-Year Asian Subpopulation Data From the CheckMate 816 Trial of Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC